Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways

Area of Science:

• Marine natural products
• Cancer biology
• DNA repair mechanisms

Background:

• Ecteinascidin 743 (ET-743) is a marine-derived compound with potent anti-tumor activity.
• Its precise mechanism of action, particularly its interaction with DNA repair pathways, requires further elucidation.

Purpose of the Study:

• To investigate the cytotoxic activity of ET-743 in cell systems with defined DNA repair deficiencies.
• To determine if ET-743's activity is linked to specific DNA repair pathways.

Main Methods:

• Assessed ET-743 cytotoxicity in yeast and mammalian cell lines with deficiencies in mismatch repair, nucleotide excision repair (NER), and DNA double-strand break repair (via DNA-PK).
• Utilized NER-proficient and -deficient cell lines (hamster and human).
• Employed human glioblastoma cell lines (MO59K and MO59J) differing in DNA-dependent protein kinase (DNA-PK) status.
• Investigated the effect of wortmannin, a DNA-PK inhibitor, on ET-743 sensitivity.

Main Results:

• ET-743 activity was unaffected by defects in mismatch repair.
• A 2- to 8-fold decrease in ET-743 activity was observed in NER-deficient cells compared to NER-proficient cells.
• Restoring NER function sensitized cells to ET-743.
• ET-743 was more effective in cells lacking DNA-PK, and DNA-PK inhibition sensitized cells to ET-743.
• Increased ET-743 sensitivity was noted in ataxia telangiectasia-mutated cells.

Conclusions:

• ET-743's cytotoxic activity is significantly influenced by nucleotide excision repair and DNA double-strand break repair pathways.
• The drug's mechanism of action appears unique and distinct from DNA-topoisomerase I poisoning.
• These findings provide critical insights into the DNA interaction of ET-743 and its potential therapeutic applications.